diclofenac has been researched along with 2-anilinophenylacetic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blobaum, AL; Marnett, LJ | 1 |
Allegretti, M; Aramini, A; Aschi, M; Bertini, R; Bizzarri, C; Cesta, MC; Crucianelli, M; Di Bitondo, R; Di Giacinto, C; Gloaguen, I; Moriconi, A; Sablone, MR | 1 |
Gu, MB; Joeng, CB; Lee, SJ; Niazi, JH | 1 |
Banerjee, S; Marnett, LJ; Valk, PL; Windsor, MA; Xu, S | 1 |
Boon, N; Hennebel, T; Meerburg, F; Vanhaecke, L; Verstraete, W | 1 |
5 other study(ies) available for diclofenac and 2-anilinophenylacetic acid
Article | Year |
---|---|
Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.
Topics: Amino Acid Substitution; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Kinetics; Male; Membrane Proteins; Mice; Models, Molecular; Mutation, Missense; Protein Binding; Protein Structure, Tertiary; Sheep; Time Factors | 2007 |
Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors.
Topics: Allosteric Regulation; Allosteric Site; Chemistry, Organic; Chemistry, Pharmaceutical; Chemotaxis; Humans; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Conformation; Mutagenesis; Mutation; Receptors, Interleukin-8A; Structure-Activity Relationship | 2009 |
ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid.
Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Aptamers, Nucleotide; Base Sequence; Binding Sites; Diclofenac; DNA, Single-Stranded; Nucleic Acid Conformation; Phenylacetates; SELEX Aptamer Technique | 2009 |
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
Topics: Animals; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Endocannabinoids; Mice; Molecular Docking Simulation | 2013 |
Diclofenac and 2-anilinophenylacetate degradation by combined activity of biogenic manganese oxides and silver.
Topics: Aniline Compounds; Biodegradation, Environmental; Diclofenac; Manganese Compounds; Oxidation-Reduction; Oxides; Phenylacetates; Pseudomonas putida; Silver; Water Pollutants, Chemical; Water Purification | 2012 |